FineHeart granted first two patents in China for the FLOWMAKER®
Extending the intellectual property of its fully implantable medical device for restoring cardiac output (ICOMS)
Bordeaux, France, April 25, 2022 - FineHeart S.A, a medical device company developing the FLOWMAKER®, a fully implantable cardiac output restoration system (ICOMS) to address the unmet needs of patients suffering from severe heart failure, announced today that its first two patents have been granted in China by the CNIPA - China National Intellectual Property Administration -.